劉 笑聡（Xiaocong Liu）
| Position | 研究員 |
|---|---|
| 研究グループ | 斎藤グループ |
| Research Field | Developmental biology, Reproductive biology |
| ORCID | https://orcid.org/0009-0009-7720-1242 |
| 着任日 | 2025/04/01 |
研究概要
略歴
Xiaocong Liu obtained her Master’s degree from Zhengzhou University (China) and received clinical training in Obstetrics and Gynecology at the First Affiliated Hospital of Zhengzhou University(2020). She completed her PhD coursework at the Graduate School of Medicine, Kyoto University under the supervision of Prof. Mitinori Saitou (2021-2025) and subsequently continued her research as a Program-Specific Researcher at the Institute for Advanced Study of Human Biology, Kyoto University.
論文
Zhang, M., Liu, X., Xu, X., Li, J., Bu, Z., Yang, Q., Shi, H., Niu, W., Dai, S., Liang, Y., & Guo, Y. (2023). The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study. Reproductive Biology and Endocrinology, 21(1), 15. https://doi.org/10.1186/s12958-023-01064-y
Wang, Z., Liu, X., Xu, J., Yang, Q., Niu, W., Dai, S., Hu, L., & Guo, Y. (2020). Paternal age, body mass index, and semen volume are associated with chromosomal aberrations-related miscarriages in couples that underwent treatment by assisted reproductive technology. Aging (Albany NY), 12(9), 8459–8472. https://doi.org/10.18632/aging.103151
Li, J., Liu, X., Hu, L., Zhang, F., Wang, F., Kong, H., Dai, S., & Guo, Y. (2019). A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology (Lausanne), 10, 834. https://doi.org/10.3389/fendo.2019.00834
Ding, W., Zhang, F. L., Liu, X. C., Hu, L. L., Dai, S. J., Li, G., Kong, H. J., & Guo, Y. H. (2019). Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle. Frontiers in Endocrinology (Lausanne), 10, 516. https://doi.org/10.3389/fendo.2019.00516
Liu, X., & Guo, Y. (2017). Anti-Mullerian Hormone: A New Potential Index for Diagnosis of Polycystic Ovary Syndrome. Journal of International Reproductive Health/Family Planning, 36(6), 44–50.